Growth and expansion for Aptamer Group in 2022
As we come to the end of 2022 and our first year as a listed company, the year in review shows a clear theme of growth and expansion across…
As we come to the end of 2022 and our first year as a listed company, the year in review shows a clear theme of growth and expansion across…
Cancer histopathology is currently the preferred method for detecting microscopic anatomical changes in tissue sections, making the discovery of cancer biomarkers critical for early diagnosis and treatment. Antibodies have…
Immunohistochemistry has helped to make surgical pathology the ‘gold standard’ for tumour diagnosis. Antibodies have been used extensively as molecular probes; however, there have been issues with their specificity,…
30th July 2019 Blood contains a range of protein biomarkers that could be used in the early detection of disease. One important biomarker is human epidermal growth factor…